Literature DB >> 19777724

Diversity in intermediate care.

Graham Paul Martin1, Susan Margaret Peet, Graham John Hewitt, Hilda Parker.   

Abstract

This paper discusses the evolution of intermediate care (IC) and presents interim observations from a survey of providers in England being conducted as part of a national evaluation. Telephone interviews covering various issues concerning the level of provision and style of delivery have been conducted with 70 services to date. Data from these are used to discuss the progress, range and nature of IC in relation to clinician viewpoints and academic and official literature on the subject. IC 'on the ground' is a multiplicitous entity, with provision apparently evolving in accordance with the particularities of local need. While protocols for medical involvement in IC generally appear to be well established, there are some tensions concerning integration of services in a locality, care management processes and questions of flexibility and inclusiveness in relation to eligibility criteria.

Mesh:

Year:  2004        PMID: 19777724     DOI: 10.1111/j.0966-0410.2004.00481.x

Source DB:  PubMed          Journal:  Health Soc Care Community        ISSN: 0966-0410


  3 in total

1.  Assessing patient preferences for the delivery of different community-based models of care using a discrete choice experiment.

Authors:  Simon Dixon; Susan A Nancarrow; Pamela M Enderby; Anna M Moran; Stuart G Parker
Journal:  Health Expect       Date:  2013-06-30       Impact factor: 3.377

Review 2.  Intermediate care: the role of medicines management.

Authors:  Anna N Millar; Carmel M Hughes; A Peter Passmore; Cristín Ryan
Journal:  Drugs Aging       Date:  2014-01       Impact factor: 3.923

3.  Study protocol for the SOFIA project: Swallowing function, Oral health, and Food Intake in old Age: a descriptive study with a cluster randomized trial.

Authors:  Patricia Hägglund; Lena Olai; Katri Ståhlnacke; Mona Persenius; Mary Hägg; Maria Andersson; Susanne Koistinen; Eva Carlsson
Journal:  BMC Geriatr       Date:  2017-03-23       Impact factor: 3.921

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.